{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T15:42:32Z","timestamp":1794498152827,"version":"4.9.1"},"reference-count":203,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32471260"],"award-info":[{"award-number":["32471260"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460809"],"award-info":[{"award-number":["82460809"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genes & Diseases"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.gendis.2025.101945","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T14:25:33Z","timestamp":1763648733000},"page":"101945","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Emerging roles of the metabolic regulator 3-hydroxy-3-methylglutaryl coenzyme-CoA reductase in human cancers: From biology to therapeutics"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0436-4277","authenticated-orcid":false,"given":"Wenfang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxiong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1955-9687","authenticated-orcid":false,"given":"Han","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengding","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.gendis.2025.101945_bib1","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.apsb.2023.12.003","article-title":"Targeting the Warburg effect: a revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer","volume":"14","author":"Liao","year":"2024","journal-title":"Acta Pharm Sin B"},{"issue":"15","key":"10.1016\/j.gendis.2025.101945_bib2","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1016\/j.cell.2024.06.026","article-title":"100 years of the Warburg effect: a cancer metabolism endeavor","volume":"187","author":"Fendt","year":"2024","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.gendis.2025.101945_bib3","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.cmet.2024.05.003","article-title":"Metabolic reprogramming in liver fibrosis","volume":"36","author":"Horn","year":"2024","journal-title":"Cell Metab"},{"issue":"10","key":"10.1016\/j.gendis.2025.101945_bib4","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","article-title":"Cancer metabolism: looking forward","volume":"21","author":"Mart\u00ednez-Reyes","year":"2021","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/j.gendis.2025.101945_bib5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41580-019-0190-7","article-title":"Mechanisms and regulation of cholesterol homeostasis","volume":"21","author":"Luo","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.pharmthera.2014.02.007","article-title":"Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease","volume":"143","author":"Yeganeh","year":"2014","journal-title":"Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.gendis.2025.101945_bib7","doi-asserted-by":"crossref","DOI":"10.4028\/b-wjQRP6","article-title":"BRCC36 deubiquitinates HMGCR to regulate the interplay between ferroptosis and pyroptosis","volume":"11","author":"Wang","year":"2024","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13058-022-01508-0","article-title":"Associations of genetically proxied inhibition of HMG-CoA reductase, NPC1L1, and PCSK9 with breast cancer and prostate cancer","volume":"24","author":"Sun","year":"2022","journal-title":"Breast Cancer Res"},{"issue":"22","key":"10.1016\/j.gendis.2025.101945_bib9","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.2174\/0929867330666230607104441","article-title":"Blockade of the lipid phenotype of prostate cancer as metabolic therapy: a theoretical proposal","volume":"31","author":"Romo-Perez","year":"2024","journal-title":"Curr Med Chem"},{"issue":"5","key":"10.1016\/j.gendis.2025.101945_bib10","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.cmet.2012.04.004","article-title":"Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease","volume":"15","author":"Min","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.gendis.2025.101945_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107293","article-title":"High expression of RUNX1 in colorectal cancer subtype accelerates malignancy by inhibiting HMGCR","volume":"206","author":"Chang","year":"2024","journal-title":"Pharmacol Res"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib12","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1038\/s41467-023-38968-7","article-title":"Epigenetic suppression of PGC1\u03b1 (PPARGC1A) causes collateral sensitivity to HMGCR-inhibitors within BRAF-treatment resistant melanomas","volume":"14","author":"Liang","year":"2023","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.gendis.2025.101945_bib13","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1053\/j.gastro.2023.02.043","article-title":"A therapeutically targetable TAZ-TEAD2 pathway drives the growth of hepatocellular carcinoma via ANLN and KIF23","volume":"164","author":"Saito","year":"2023","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.gendis.2025.101945_bib14","article-title":"Inhibiting HMGCR represses stemness and metastasis of hepatocellular carcinoma via Hedgehog signaling","volume":"11","author":"Zhang","year":"2024","journal-title":"Genes Dis"},{"issue":"7838","key":"10.1016\/j.gendis.2025.101945_bib15","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41586-020-2928-y","article-title":"Feeding induces cholesterol biosynthesis via the mTORC1-USP20-HMGCR axis","volume":"588","author":"Lu","year":"2020","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.gendis.2025.101945_bib16","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.tibs.2004.09.006","article-title":"The power of two: protein dimerization in biology","volume":"29","author":"Marianayagam","year":"2004","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib17","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1038\/s41467-022-32025-5","article-title":"Regulated degradation of HMG CoA reductase requires conformational changes in sterol-sensing domain","volume":"13","author":"Chen","year":"2022","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.gendis.2025.101945_bib18","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/gb-2004-5-11-248","article-title":"The 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductases","volume":"5","author":"Friesen","year":"2004","journal-title":"Genome Biol"},{"issue":"5519","key":"10.1016\/j.gendis.2025.101945_bib19","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.1059344","article-title":"Structural mechanism for statin inhibition of HMG-CoA reductase","volume":"292","author":"Istvan","year":"2001","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.gendis.2025.101945_bib20","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1021\/acs.biochem.7b00999","article-title":"Structural features and domain movements controlling substrate binding and cofactor specificity in class II HMG-CoA reductase","volume":"57","author":"Miller","year":"2018","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib21","doi-asserted-by":"crossref","first-page":"5138","DOI":"10.1038\/s41467-018-07590-3","article-title":"Discovery of a potent HMG-CoA reductase degrader that eliminates statin-induced reductase accumulation and lowers cholesterol","volume":"9","author":"Jiang","year":"2018","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.gendis.2025.101945_bib22","article-title":"Post-translational regulation of HMG CoA reductase","volume":"14","author":"Jo","year":"2022","journal-title":"Cold Spring Harbor Perspect Biol"},{"key":"10.1016\/j.gendis.2025.101945_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101919","article-title":"Acetaldehyde Dehydrogenase 2 regulates HMG-CoA reductase stability and cholesterol synthesis in the liver","volume":"41","author":"Zhong","year":"2021","journal-title":"Redox Biol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/pro.3022","article-title":"How cryo-electron microscopy and X-ray crystallography complement each other","volume":"26","author":"Wang","year":"2017","journal-title":"Protein Sci"},{"issue":"5","key":"10.1016\/j.gendis.2025.101945_bib25","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/emboj\/19.5.819","article-title":"Crystal structure of the catalytic portion of human HMG-CoA reductase: insights into regulation of activity and catalysis","volume":"19","author":"Istvan","year":"2000","journal-title":"EMBO J"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41392-022-01125-5","article-title":"Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics","volume":"7","author":"Duan","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"15","key":"10.1016\/j.gendis.2025.101945_bib27","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1042\/CS20220752","article-title":"Regulation of cholesterol homeostasis in osteoporosis mechanisms and therapeutics","volume":"137","author":"Bao","year":"2023","journal-title":"Clin Sci (Lond)"},{"issue":"48","key":"10.1016\/j.gendis.2025.101945_bib28","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1038\/onc.2012.6","article-title":"Targeting tumor cell metabolism with statins","volume":"31","author":"Clendening","year":"2012","journal-title":"Oncogene"},{"issue":"845","key":"10.1016\/j.gendis.2025.101945_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.add8913","article-title":"Glucose-oxygen deprivation constrains HMGCR function and Rac1 prenylation and activates the NLRP3 inflammasome in human monocytes","volume":"17","author":"Raulien","year":"2024","journal-title":"Sci Signal"},{"issue":"6","key":"10.1016\/j.gendis.2025.101945_bib30","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1089\/thy.2020.0636","article-title":"Hypothyroidism increases cholesterol gallstone prevalence in mice by elevated hydrophobicity of primary bile acids","volume":"31","author":"Kube","year":"2021","journal-title":"Thyroid"},{"issue":"3661","key":"10.1016\/j.gendis.2025.101945_bib31","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1126\/science.147.3661.1038.a","article-title":"Cholesterol biosynthesis: mevalonate synthesis inhibited by bile salts","volume":"147","author":"Fimognari","year":"1965","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.gendis.2025.101945_bib32","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ccell.2023.03.002","article-title":"Targeting the mevalonate pathway suppresses ARID1A-inactivated cancers by promoting pyroptosis","volume":"41","author":"Zhou","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.gendis.2025.101945_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113920","article-title":"Inhibition of SREBP-mediated lipid biosynthesis and activation of multiple anticancer mechanisms by platinum complexes: ascribe possibilities of new antitumor strategies","volume":"227","author":"Bai","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.gendis.2025.101945_bib34","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0065-2571(86)90022-1","article-title":"Phosphorylation state of HMG CoA reductase affects its catalytic activity and degradation","volume":"25","author":"Parker","year":"1986","journal-title":"Adv Enzym Regul"},{"key":"10.1016\/j.gendis.2025.101945_bib35","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0065-2571(89)90064-2","article-title":"Phosphorylation and degradation of HMG CoA reductase","volume":"28","author":"Miller","year":"1989","journal-title":"Adv Enzym Regul"},{"issue":"10","key":"10.1016\/j.gendis.2025.101945_bib36","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1194\/jlr.RA119000201","article-title":"Endogenous sterol intermediates of the mevalonate pathway regulate HMGCR degradation and SREBP-2 processing","volume":"60","author":"Chen","year":"2019","journal-title":"J Lipid Res"},{"issue":"3","key":"10.1016\/j.gendis.2025.101945_bib37","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3390\/nu12030610","article-title":"Unripe Rubus coreanus miquel extract containing ellagic acid regulates AMPK, SREBP-2, HMGCR, and INSIG-1 signaling and cholesterol metabolism in vitro and in vivo","volume":"12","author":"Lee","year":"2020","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib38","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3390\/ijms24010187","article-title":"Ameliorative effect of ethanolic Echinacea purpurea against hyperthyroidism-induced oxidative stress via AMRK and PPAR signal pathway using transcriptomics and network pharmacology analysis","volume":"24","author":"Zhu","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.gendis.2025.101945_bib39","doi-asserted-by":"crossref","first-page":"490","DOI":"10.5604\/01.3001.0011.7394","article-title":"Potential molecular targets of statins in the prevention of hepatocarcinogenesis","volume":"17","author":"Ridruejo","year":"2018","journal-title":"Ann Hepatol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib40","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12943-021-01420-9","article-title":"AMPK promotes antitumor immunity by downregulating PD-1 in regulatory T cells via the HMGCR\/p38 signaling pathway","volume":"20","author":"Pokhrel","year":"2021","journal-title":"Mol Cancer"},{"issue":"6","key":"10.1016\/j.gendis.2025.101945_bib41","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.cmet.2008.09.004","article-title":"Insig regulates HMG-CoA reductase by controlling enzyme phosphorylation in fission yeast","volume":"8","author":"Burg","year":"2008","journal-title":"Cell Metab"},{"key":"10.1016\/j.gendis.2025.101945_bib42","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.3389\/fonc.2020.01510","article-title":"Targeting SREBP-2-regulated mevalonate metabolism for cancer therapy","volume":"10","author":"Xue","year":"2020","journal-title":"Front Oncol"},{"issue":"10","key":"10.1016\/j.gendis.2025.101945_bib43","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1194\/jlr.M039339","article-title":"Hepatic SREBP-2 and cholesterol biosynthesis are regulated by FoxO3 and Sirt6","volume":"54","author":"Tao","year":"2013","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib44","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/hep4.1279","article-title":"Inhibition of adenosine monophosphate-activated protein kinase-3-hydroxy-3-methylglutaryl coenzyme a reductase signaling leads to hypercholesterolemia and promotes hepatic steatosis and insulin resistance","volume":"3","author":"Loh","year":"2019","journal-title":"Hepatol Commun"},{"issue":"4","key":"10.1016\/j.gendis.2025.101945_bib45","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/cbin.10915","article-title":"Mechanisms of AMPK in the maintenance of ATP balance during energy metabolism","volume":"42","author":"Ke","year":"2018","journal-title":"Cell Biol Int"},{"issue":"14","key":"10.1016\/j.gendis.2025.101945_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115576","article-title":"Bisphosphonate esters interact with HMG-CoA reductase membrane domain to induce its degradation","volume":"28","author":"Toyota","year":"2020","journal-title":"Bioorg Med Chem"},{"issue":"4","key":"10.1016\/j.gendis.2025.101945_bib47","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41419-019-1544-y","article-title":"The mevalonate coordinates energy input and cell proliferation","volume":"10","author":"Gong","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.gendis.2025.101945_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.626971","article-title":"The mevalonate pathway, a metabolic target in cancer therapy","volume":"11","author":"Guerra","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.gendis.2025.101945_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14132","article-title":"Human farnesyl pyrophosphate synthase is allosterically inhibited by its own product","volume":"8","author":"Park","year":"2017","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.gendis.2025.101945_bib50","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1210\/en.2011-0016","article-title":"Effects of farnesyl pyrophosphate accumulation on calvarial osteoblast differentiation","volume":"152","author":"Weivoda","year":"2011","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib51","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1038\/s41467-022-30060-w","article-title":"Statin therapy inhibits fatty acid synthase via dynamic protein modifications","volume":"13","author":"Trub","year":"2022","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.gendis.2025.101945_bib52","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41419-019-1322-x","article-title":"Induction of 3-hydroxy-3-methylglutaryl-CoA reductase mediates statin resistance in breast cancer cells","volume":"10","author":"G\u00f6bel","year":"2019","journal-title":"Cell Death Dis"},{"issue":"5","key":"10.1016\/j.gendis.2025.101945_bib53","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1194\/jlr.M047654","article-title":"Thyroid-stimulating hormone decreases HMG-CoA reductase phosphorylation via AMP-activated protein kinase in the liver","volume":"56","author":"Zhang","year":"2015","journal-title":"J Lipid Res"},{"issue":"2","key":"10.1016\/j.gendis.2025.101945_bib54","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.apsb.2021.09.019","article-title":"Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma","volume":"12","author":"Du","year":"2022","journal-title":"Acta Pharm Sin B"},{"issue":"12","key":"10.1016\/j.gendis.2025.101945_bib55","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1194\/jlr.RA120001006","article-title":"Depletion of essential isoprenoids and ER stress induction following acute liver-specific deletion of HMG-CoA reductase","volume":"61","author":"De Giorgi","year":"2020","journal-title":"J Lipid Res"},{"issue":"7","key":"10.1016\/j.gendis.2025.101945_bib56","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2318822121","article-title":"Direct binding to sterols accelerates endoplasmic reticulum-associated degradation of HMG CoA reductase","volume":"121","author":"Faulkner","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.gendis.2025.101945_bib57","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.tibs.2018.01.005","article-title":"SREBPs in lipid metabolism, insulin signaling, and beyond","volume":"43","author":"DeBose-Boyd","year":"2018","journal-title":"Trends Biochem Sci"},{"issue":"2","key":"10.1016\/j.gendis.2025.101945_bib58","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3390\/ijms25021109","article-title":"The role of SCAP\/SREBP as central regulators of lipid metabolism in hepatic steatosis","volume":"25","author":"Chandrasekaran","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.gendis.2025.101945_bib59","first-page":"661","article-title":"Expression of follicle-stimulating hormone receptor (FSHR), protein kinase B-2 (AKT2) and adapter protein with PH domain, PTB domain, and leucine zipper (APPL1) in pig ovaries","volume":"20","author":"Zhou","year":"2017","journal-title":"Pol J Vet Sci"},{"issue":"2","key":"10.1016\/j.gendis.2025.101945_bib60","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41422-018-0123-6","article-title":"Blocking FSH inhibits hepatic cholesterol biosynthesis and reduces serum cholesterol","volume":"29","author":"Guo","year":"2019","journal-title":"Cell Res"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib61","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1038\/s41467-021-26787-7","article-title":"MMAB promotes negative feedback control of cholesterol homeostasis","volume":"12","author":"Goedeke","year":"2021","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.gendis.2025.101945_bib62","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/hep.29206","article-title":"A novel role for CRTC2 in hepatic cholesterol synthesis through SREBP-2","volume":"66","author":"Li","year":"2017","journal-title":"Hepatology"},{"issue":"7564","key":"10.1016\/j.gendis.2025.101945_bib63","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nature14557","article-title":"The CREB coactivator CRTC2 controls hepatic lipid metabolism by regulating SREBP1","volume":"524","author":"Han","year":"2015","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.gendis.2025.101945_bib64","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1038\/s41388-018-0570-z","article-title":"CtBP promotes metastasis of breast cancer through repressing cholesterol and activating TGF-\u03b2 signaling","volume":"38","author":"Zhao","year":"2019","journal-title":"Oncogene"},{"issue":"13","key":"10.1016\/j.gendis.2025.101945_bib65","doi-asserted-by":"crossref","first-page":"6933","DOI":"10.3390\/ijms23136933","article-title":"Prognostic significance of HMGA1 expression in lung cancer based on bioinformatics analysis","volume":"23","author":"Saed","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.gendis.2025.101945_bib66","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1093\/nar\/gkq012","article-title":"Profiling of promoter occupancy by PPARalpha in human hepatoma cells via ChIP-chip analysis","volume":"38","author":"van der Meer","year":"2010","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib67","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/HEP.0000000000000672","article-title":"MicroRNA-206-3p suppresses hepatic lipogenesis and cholesterol synthesis while driving cholesterol efflux","volume":"81","author":"Liu","year":"2025","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.gendis.2025.101945_bib68","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/hmg\/ddt422","article-title":"HNRNPA1 regulates HMGCR alternative splicing and modulates cellular cholesterol metabolism","volume":"23","author":"Yu","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1016\/j.gendis.2025.101945_bib69","doi-asserted-by":"crossref","first-page":"265","DOI":"10.31083\/j.jin2002026","article-title":"RNA-binding protein hnRNPR reduces neuronal cholesterol levels by binding to and suppressing HMGCR","volume":"20","author":"Agbo","year":"2021","journal-title":"J Integr Neurosci"},{"issue":"7","key":"10.1016\/j.gendis.2025.101945_bib70","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1161\/CIRCRESAHA.115.305467","article-title":"Cholesterol homeostasis regulation by miR-223: basic science mechanisms and translational implications","volume":"116","author":"Nishi","year":"2015","journal-title":"Circ Res"},{"issue":"11","key":"10.1016\/j.gendis.2025.101945_bib71","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.tibs.2014.08.008","article-title":"The UPS and downs of cholesterol homeostasis","volume":"39","author":"Sharpe","year":"2014","journal-title":"Trends Biochem Sci"},{"issue":"2","key":"10.1016\/j.gendis.2025.101945_bib72","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cmet.2012.06.014","article-title":"Ablation of gp78 in liver improves hyperlipidemia and insulin resistance by inhibiting SREBP to decrease lipid biosynthesis","volume":"16","author":"Liu","year":"2012","journal-title":"Cell Metab"},{"issue":"51","key":"10.1016\/j.gendis.2025.101945_bib73","doi-asserted-by":"crossref","first-page":"20503","DOI":"10.1073\/pnas.1112831108","article-title":"Sterol-induced degradation of HMG CoA reductase depends on interplay of two Insigs and two ubiquitin ligases, gp78 and Trc8","volume":"108","author":"Jo","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.gendis.2025.101945_bib74","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cmet.2007.07.002","article-title":"Ufd1 is a cofactor of gp78 and plays a key role in cholesterol metabolism by regulating the stability of HMG-CoA reductase","volume":"6","author":"Cao","year":"2007","journal-title":"Cell Metab"},{"issue":"17","key":"10.1016\/j.gendis.2025.101945_bib75","doi-asserted-by":"crossref","first-page":"15022","DOI":"10.1074\/jbc.M110.211326","article-title":"Membrane-associated ubiquitin ligase complex containing gp78 mediates sterol-accelerated degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase","volume":"286","author":"Jo","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.gendis.2025.101945_bib76","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.40009","article-title":"The sterol-responsive RNF145 E3 ubiquitin ligase mediates the degradation of HMG-CoA reductase together with gp78 and Hrd1","volume":"7","author":"Menzies","year":"2018","journal-title":"eLife"},{"issue":"11","key":"10.1016\/j.gendis.2025.101945_bib77","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1074\/jbc.RA117.001260","article-title":"Ring finger protein 145 (RNF145) is a ubiquitin ligase for sterol-induced degradation of HMG-CoA reductase","volume":"293","author":"Jiang","year":"2018","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.gendis.2025.101945_bib78","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1128\/MCB.01140-13","article-title":"The E3 ubiquitin ligase MARCH6 degrades squalene monooxygenase and affects 3-hydroxy-3-methyl-glutaryl coenzyme A reductase and the cholesterol synthesis pathway","volume":"34","author":"Zelcer","year":"2014","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.gendis.2025.101945_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115306","article-title":"miR-133a-3p\/Sirt1 epigenetic programming mediates hypercholesterolemia susceptibility in female offspring induced by prenatal dexamethasone exposure","volume":"206","author":"Li","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.gendis.2025.101945_bib80","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3389\/fgene.2014.00311","article-title":"Epigenetic regulation of cholesterol homeostasis","volume":"5","author":"Meaney","year":"2014","journal-title":"Front Genet"},{"key":"10.1016\/j.gendis.2025.101945_bib81","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2147\/DMSO.S219013","article-title":"Therapeutic targets of hypercholesterolemia: HMGCR and LDLR","volume":"12","author":"Ma","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib82","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4103\/0366-6999.147824","article-title":"Long non-coding RNAs expression profile in HepG2 cells reveals the potential role of long non-coding RNAs in the cholesterol metabolism","volume":"128","author":"Liu","year":"2015","journal-title":"Chin Med J"},{"key":"10.1016\/j.gendis.2025.101945_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107539","article-title":"Gypenoside L inhibits hepatocellular carcinoma by targeting the SREBP2-HMGCS1 axis and enhancing immune response","volume":"150","author":"Xiao","year":"2024","journal-title":"Bioorg Chem"},{"issue":"12","key":"10.1016\/j.gendis.2025.101945_bib84","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1002\/ijc.30709","article-title":"Mendelian randomisation implicates hyperlipidaemia as a risk factor for colorectal cancer","volume":"140","author":"Rodriguez-Broadbent","year":"2017","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib85","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003988","article-title":"Association between genetically proxied PCSK9 inhibition and prostate cancer risk: a Mendelian randomisation study","volume":"20","author":"Fang","year":"2023","journal-title":"PLoS Med"},{"key":"10.1016\/j.gendis.2025.101945_bib86","doi-asserted-by":"crossref","first-page":"9015","DOI":"10.2147\/CMAR.S337873","article-title":"Low-density lipoprotein receptor (LDLR) and 3-hydroxy-3-methylglutaryl coenzyme a reductase (HMGCR) expression are associated with platinum-resistance and prognosis in ovarian carcinoma patients","volume":"13","author":"Huang","year":"2021","journal-title":"Cancer Manag Res"},{"issue":"4","key":"10.1016\/j.gendis.2025.101945_bib87","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.cell.2018.08.070","article-title":"The mevalonate pathway is a druggable target for vaccine adjuvant discovery","volume":"175","author":"Xia","year":"2018","journal-title":"Cell"},{"issue":"1 Pt 1","key":"10.1016\/j.gendis.2025.101945_bib88","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.gene.2015.09.067","article-title":"HMGCR positively regulated the growth and migration of glioblastoma cells","volume":"576","author":"Qiu","year":"2016","journal-title":"Gene"},{"issue":"20","key":"10.1016\/j.gendis.2025.101945_bib89","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222011107","article-title":"Atorvastatin ester regulates lipid metabolism in hyperlipidemia rats via the PPAR-signaling pathway and HMGCR expression in the liver","volume":"22","author":"Hu","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib90","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/cancers15010003","article-title":"Rewiring lipid metabolism by targeting PCSK9 and HMGCR to treat liver cancer","volume":"15","author":"Alannan","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib91","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41598-019-57323-9","article-title":"Statin use, HMGCR expression, and breast cancer survival - the Malm\u00f6 Diet and Cancer Study","volume":"10","author":"Bjarnadottir","year":"2020","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.gendis.2025.101945_bib92","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s00432-024-05607-7","article-title":"Role of hydroxymethylglutharyl-coenzyme A reductase in the induction of stem-like states in breast cancer","volume":"150","author":"Marks","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"10.1016\/j.gendis.2025.101945_bib93","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1093\/ije\/dyz047","article-title":"Body mass index and the association between low-density lipoprotein cholesterol as predicted by HMGCR genetic variants and breast cancer risk","volume":"48","author":"Kar","year":"2019","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib94","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-91928-3","article-title":"Concomitant attenuation of HMGCR expression and activity enhances the growth inhibitory effect of atorvastatin on TGF-\u03b2-treated epithelial cancer cells","volume":"11","author":"Warita","year":"2021","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.gendis.2025.101945_bib95","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jphs.2023.08.002","article-title":"CYP11A1 silencing suppresses HMGCR expression via cholesterol accumulation and sensitizes CRPC cell line DU-145 to atorvastatin","volume":"153","author":"Tashiro","year":"2023","journal-title":"J Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib96","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.gene.2016.04.029","article-title":"HMGCR is up-regulated in gastric cancer and promotes the growth and migration of the cancer cells","volume":"587","author":"Li","year":"2016","journal-title":"Gene"},{"issue":"2","key":"10.1016\/j.gendis.2025.101945_bib97","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10549-013-2473-6","article-title":"Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial","volume":"138","author":"Bjarnadottir","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"10.1016\/j.gendis.2025.101945_bib98","first-page":"6533","article-title":"Stromal regulation of prostate cancer cell growth by mevalonate pathway enzymes HMGCS1 and HMGCR","volume":"14","author":"Ashida","year":"2017","journal-title":"Oncol Lett"},{"key":"10.1016\/j.gendis.2025.101945_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.149841","article-title":"Overcoming statin resistance in prostate cancer cells by targeting the 3-hydroxy-3-methylglutaryl-CoA-reductase","volume":"710","author":"G\u00f6bel","year":"2024","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib100","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/gutjnl-2018-317581","article-title":"Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans","volume":"69","author":"Che","year":"2020","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.gendis.2025.101945_bib101","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.bbalip.2019.06.008","article-title":"Clinical relevance of cholesterol homeostasis genes in colorectal cancer","volume":"1864","author":"Sharma","year":"2019","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"9","key":"10.1016\/j.gendis.2025.101945_bib102","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1038\/s12276-023-01079-w","article-title":"Functional significance of cholesterol metabolism in cancer: from threat to treatment","volume":"55","author":"Xiao","year":"2023","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.gendis.2025.101945_bib103","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1746-1596-9-78","article-title":"HMG-CoA reductase expression in primary colorectal cancer correlates with favourable clinicopathological characteristics and an improved clinical outcome","volume":"9","author":"Bengtsson","year":"2014","journal-title":"Diagn Pathol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib104","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41419-019-2221-x","article-title":"SIK2 enhances synthesis of fatty acid and cholesterol in ovarian cancer cells and tumor growth through PI3K\/Akt signaling pathway","volume":"11","author":"Zhao","year":"2020","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib105","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41419-020-03336-6","article-title":"MIEF2 reprograms lipid metabolism to drive progression of ovarian cancer through ROS\/AKT\/mTOR signaling pathway","volume":"12","author":"Zhao","year":"2021","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib106","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.1038\/s41598-023-31575-y","article-title":"Contribution of serum lipids and cholesterol cellular metabolism in lung cancer development and progression","volume":"13","author":"Hartmann","year":"2023","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib107","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12935-023-02914-w","article-title":"SIAH1 ubiquitination-modified HMGCR inhibits lung cancer progression and promotes drug sensitivity through cholesterol synthesis","volume":"23","author":"Yuan","year":"2023","journal-title":"Cancer Cell Int"},{"issue":"10","key":"10.1016\/j.gendis.2025.101945_bib108","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3390\/biom9100620","article-title":"YAP inhibition by nuciferine via AMPK-mediated downregulation of HMGCR sensitizes pancreatic cancer cells to gemcitabine","volume":"9","author":"Zhou","year":"2019","journal-title":"Biomolecules"},{"issue":"21","key":"10.1016\/j.gendis.2025.101945_bib109","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.3390\/cancers15215177","article-title":"Cholesterol metabolism in pancreatic cancer","volume":"15","author":"Rebelo","year":"2023","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.gendis.2025.101945_bib110","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3390\/cancers11020146","article-title":"Cholesterol metabolism: a potential therapeutic target in glioblastoma","volume":"11","author":"Ahmad","year":"2019","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib111","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.taap.2014.08.033","article-title":"Up-regulation of cholesterol associated genes as novel resistance mechanism in glioblastoma cells in response to archazolid B","volume":"281","author":"Hamm","year":"2014","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"10.1016\/j.gendis.2025.101945_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188351","article-title":"Cholesterol and beyond - the role of the mevalonate pathway in cancer biology","volume":"1873","author":"G\u00f6bel","year":"2020","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"40","key":"10.1016\/j.gendis.2025.101945_bib113","doi-asserted-by":"crossref","first-page":"6340","DOI":"10.1038\/s41388-020-01439-0","article-title":"Isocitrate dehydrogenase 1 mutation enhances 24(S)-hydroxycholesterol production and alters cholesterol homeostasis in glioma","volume":"39","author":"Yang","year":"2020","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.gendis.2025.101945_bib114","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/carcin\/bgaa036","article-title":"BAI1 acts as a tumor suppressor in lung cancer A549 cells by inducing metabolic reprogramming via the SCD1\/HMGCR module","volume":"41","author":"Liu","year":"2020","journal-title":"Carcinogenesis"},{"issue":"9","key":"10.1016\/j.gendis.2025.101945_bib115","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s00018-022-04504-x","article-title":"Unspliced XBP1 contributes to cholesterol biosynthesis and tumorigenesis by stabilizing SREBP2 in hepatocellular carcinoma","volume":"79","author":"Wei","year":"2022","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib116","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1158\/1055-9965.EPI-07-0531","article-title":"Statin induces apoptosis and cell growth arrest in prostate cancer cells","volume":"17","author":"Hoque","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"10.1016\/j.gendis.2025.101945_bib117","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1002\/ptr.7735","article-title":"Targeting lipid metabolism with natural products: a novel strategy for gastrointestinal cancer therapy","volume":"37","author":"Guo","year":"2023","journal-title":"Phytother Res"},{"issue":"4","key":"10.1016\/j.gendis.2025.101945_bib118","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/neuonc\/noad233","article-title":"Cholesterol homeostasis confers glioma malignancy triggered by hnRNPA2B1-dependent regulation of SREBP2 and LDLR","volume":"26","author":"Zhang","year":"2024","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.gendis.2025.101945_bib119","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.lfs.2018.04.028","article-title":"Long noncoding RNA lncARSR promotes hepatic cholesterol biosynthesis via modulating Akt\/SREBP-2\/HMGCR pathway","volume":"203","author":"Huang","year":"2018","journal-title":"Life Sci"},{"issue":"6","key":"10.1016\/j.gendis.2025.101945_bib120","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/s41401-021-00745-x","article-title":"Identification of HMGCR as the anticancer target of physapubenolide against melanoma cells by in silico target prediction","volume":"43","author":"Wang","year":"2022","journal-title":"Acta Pharmacol Sin"},{"issue":"10","key":"10.1016\/j.gendis.2025.101945_bib121","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1016\/j.ymthe.2021.05.012","article-title":"Targeting cholesterol biosynthesis promotes anti-tumor immunity by inhibiting long noncoding RNA SNHG29-mediated YAP activation","volume":"29","author":"Ni","year":"2021","journal-title":"Mol Ther"},{"issue":"4","key":"10.1016\/j.gendis.2025.101945_bib122","article-title":"The roles and mechanisms of SREBP1 in cancer development and drug response","volume":"11","author":"He","year":"2024","journal-title":"Genes Dis"},{"issue":"8","key":"10.1016\/j.gendis.2025.101945_bib123","doi-asserted-by":"crossref","first-page":"4716","DOI":"10.1097\/JS9.0000000000001582","article-title":"Statins inhibit paclitaxel-induced PD-L1 expression and increase CD8+ T cytotoxicity for better prognosis in breast cancer","volume":"110","author":"Li","year":"2024","journal-title":"Int J Surg"},{"issue":"4248","key":"10.1016\/j.gendis.2025.101945_bib124","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1126\/science.935865","article-title":"Mevalonate metabolism: role of kidneys","volume":"193","author":"Edmond","year":"1976","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.gendis.2025.101945_bib125","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/s41419-023-06357-z","article-title":"p140Cap modulates the mevalonate pathway decreasing cell migration and enhancing drug sensitivity in breast cancer cells","volume":"14","author":"Centonze","year":"2023","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib126","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41392-024-01887-0","article-title":"Semaphorin 3C (Sema3C) reshapes stromal microenvironment to promote hepatocellular carcinoma progression","volume":"9","author":"Peng","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib127","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1186\/s13046-021-02191-3","article-title":"The IRF2\/CENP-N\/AKT signaling axis promotes proliferation, cell cycling and apoptosis resistance in nasopharyngeal carcinoma cells by increasing aerobic glycolysis","volume":"40","author":"Qi","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.gendis.2025.101945_bib128","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/s41401-022-01010-5","article-title":"Ferroptosis inhibitor liproxstatin-1 alleviates metabolic dysfunction-associated fatty liver disease in mice: potential involvement of PANoptosis","volume":"44","author":"Tong","year":"2023","journal-title":"Acta Pharmacol Sin"},{"issue":"10","key":"10.1016\/j.gendis.2025.101945_bib129","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1038\/s41375-023-01993-y","article-title":"TAL1 hijacks MYCN enhancer that induces MYCN expression and dependence on mevalonate pathway in T-cell acute lymphoblastic leukemia","volume":"37","author":"Tan","year":"2023","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.gendis.2025.101945_bib130","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.cmet.2025.01.005","article-title":"The emerging role of dysregulated propionate metabolism and methylmalonic acid in metabolic disease, aging, and cancer","volume":"37","author":"Shafer","year":"2025","journal-title":"Cell Metab"},{"issue":"7","key":"10.1016\/j.gendis.2025.101945_bib131","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00109-019-01784-y","article-title":"Mevalonate promotes differentiation of regulatory T cells","volume":"97","author":"Acharya","year":"2019","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.gendis.2025.101945_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154896","article-title":"Citri Reticulatae Pericarpium-Reynoutria japonica Houtt. herb pair suppresses breast cancer liver metastasis by targeting ECM1-mediated cholesterol biosynthesis pathway","volume":"116","author":"Wang","year":"2023","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib133","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s12967-023-04236-x","article-title":"NUCB2\/Nesfatin-1 drives breast cancer metastasis through the up-regulation of cholesterol synthesis via the mTORC1 pathway","volume":"21","author":"Ning","year":"2023","journal-title":"J Transl Med"},{"issue":"401","key":"10.1016\/j.gendis.2025.101945_bib134","doi-asserted-by":"crossref","first-page":"ra111","DOI":"10.1126\/scisignal.aac5124","article-title":"Neuregulin-activated ERBB4 induces the SREBP-2 cholesterol biosynthetic pathway and increases low-density lipoprotein uptake","volume":"8","author":"Haskins","year":"2015","journal-title":"Sci Signal"},{"issue":"8802","key":"10.1016\/j.gendis.2025.101945_bib135","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/0140-6736(92)90744-N","article-title":"Cholesterol inhibition, cancer, and chemotherapy","volume":"339","author":"Buchwald","year":"1992","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.gendis.2025.101945_bib136","article-title":"Statins as anti-tumor agents: a paradigm for repurposed drugs","volume":"7","author":"Tripathi","year":"2024","journal-title":"Cancer Rep (Hoboken)"},{"issue":"4","key":"10.1016\/j.gendis.2025.101945_bib137","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/joim.12806","article-title":"Statins: a role in breast cancer therapy?","volume":"284","author":"Borgquist","year":"2018","journal-title":"J Intern Med"},{"issue":"2","key":"10.1016\/j.gendis.2025.101945_bib138","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41577-018-0094-3","article-title":"Statins: a viable candidate for host-directed therapy against infectious diseases","volume":"19","author":"Parihar","year":"2019","journal-title":"Nat Rev Immunol"},{"issue":"19","key":"10.1016\/j.gendis.2025.101945_bib139","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1158\/0008-5472.CAN-24-0970","article-title":"Targeting cholesterol biosynthesis with statins synergizes with AKT inhibitors in triple-negative breast cancer","volume":"84","author":"Hillis","year":"2024","journal-title":"Cancer Res"},{"key":"10.1016\/j.gendis.2025.101945_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2024.111045","article-title":"Simvastatin alleviates glymphatic system damage via the VEGF-C\/VEGFR3\/PI3K-Akt pathway after experimental intracerebral hemorrhage","volume":"216","author":"Liao","year":"2024","journal-title":"Brain Res Bull"},{"issue":"10","key":"10.1016\/j.gendis.2025.101945_bib141","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.autrev.2016.07.023","article-title":"Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: a history of statins and experience from a large international multi-center study","volume":"15","author":"Musset","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1016\/j.gendis.2025.101945_bib142","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-232406","article-title":"Statin-induced anti-HMGCR antibody-related immune-mediated necrotising myositis achieving complete remission with rituximab","volume":"12","author":"Zhang","year":"2019","journal-title":"BMJ Case Rep"},{"issue":"6911","key":"10.1016\/j.gendis.2025.101945_bib143","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nature01158","article-title":"The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease","volume":"420","author":"Youssef","year":"2002","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib144","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-67706-2","article-title":"Atorvastatin lowers breast cancer risk by reversing an early tumorigenic signature","volume":"14","author":"Foda","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.gendis.2025.101945_bib145","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bbrc.2023.07.056","article-title":"HMG-CoA reductase degrader, SR-12813, counteracts statin-induced upregulation of HMG-CoA reductase and augments the anticancer effect of atorvastatin","volume":"677","author":"Zhou","year":"2023","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib146","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s13046-021-02041-2","article-title":"Statins: a repurposed drug to fight cancer","volume":"40","author":"Jiang","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"issue":"22","key":"10.1016\/j.gendis.2025.101945_bib147","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.1158\/1078-0432.CCR-20-1967","article-title":"Statins as anticancer agents in the era of precision medicine","volume":"26","author":"Longo","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.gendis.2025.101945_bib148","article-title":"Advances in ovarian cancer treatment using a combination of statins with other drugs","volume":"13","author":"Xia","year":"2022","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib149","doi-asserted-by":"crossref","first-page":"946","DOI":"10.18632\/oncotarget.5834","article-title":"The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer","volume":"7","author":"Stine","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.gendis.2025.101945_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.173915","article-title":"Statins as adjuvants in the treatment of ovarian cancer: controversy and misunderstanding","volume":"896","author":"Manzano-Le\u00f3n","year":"2021","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.gendis.2025.101945_bib151","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1586\/14779072.1.4.495","article-title":"Rosuvastatin: a new inhibitor of HMG-coA reductase for the treatment of dyslipidemia","volume":"1","author":"Rosenson","year":"2003","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"4","key":"10.1016\/j.gendis.2025.101945_bib152","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1527-3466.2002.tb00099.x","article-title":"Rosuvastatin: a highly effective new HMG-CoA reductase inhibitor","volume":"20","author":"Olsson","year":"2002","journal-title":"Cardiovasc Drug Rev"},{"key":"10.1016\/j.gendis.2025.101945_bib153","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.gene.2018.03.092","article-title":"Effects of Rosuvastatin on the expression of the genes involved in cholesterol metabolism in rats: adaptive responses by extrahepatic tissues","volume":"661","author":"Ahmadi","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.gendis.2025.101945_bib154","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.2147\/IJN.S294916","article-title":"Rosuvastatin nanomicelles target neuroinflammation and improve neurological deficit in a mouse model of intracerebral hemorrhage","volume":"16","author":"Zi","year":"2021","journal-title":"Int J Nanomed"},{"issue":"12","key":"10.1016\/j.gendis.2025.101945_bib155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0278282","article-title":"The prognosis of lipid reprogramming with the HMG-CoA reductase inhibitor, rosuvastatin, in castrated Egyptian prostate cancer patients: randomized trial","volume":"17","author":"Karkeet","year":"2022","journal-title":"PLoS One"},{"issue":"23","key":"10.1016\/j.gendis.2025.101945_bib156","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242316814","article-title":"Lovastatin treatment inducing apoptosis in human pancreatic cancer cells by inhibiting cholesterol rafts in plasma membrane and mitochondria","volume":"24","author":"Gyoten","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib157","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12885-023-10742-4","article-title":"Lovastatin inhibits erythroleukemia progression through KLF2-mediated suppression of MAPK\/ERK signaling","volume":"23","author":"Gao","year":"2023","journal-title":"BMC Cancer"},{"issue":"129","key":"10.1016\/j.gendis.2025.101945_bib158","first-page":"1","article-title":"Lovastatin inhibited the growth of gastric cancer cells","volume":"61","author":"Yang","year":"2014","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.gendis.2025.101945_bib159","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.916661","article-title":"The role of lipid metabolism in gastric cancer","volume":"12","author":"Cui","year":"2022","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib160","doi-asserted-by":"crossref","first-page":"5410","DOI":"10.1038\/s41598-017-05595-4","article-title":"Dietary geranylgeraniol can limit the activity of pitavastatin as a potential treatment for drug-resistant ovarian cancer","volume":"7","author":"de Wolf","year":"2017","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.gendis.2025.101945_bib161","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3390\/ph14050470","article-title":"Statin as a potential chemotherapeutic agent: current updates as a monotherapy, combination therapy, and treatment for anti-cancer drug resistance","volume":"14","author":"Tilija Pun","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"9000","key":"10.1016\/j.gendis.2025.101945_bib162","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0140-6736(96)91185-X","article-title":"Statins, cholesterol, and mevalonate pathways?","volume":"347","author":"Lewis","year":"1996","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.gendis.2025.101945_bib163","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2174\/1389450116666150330114850","article-title":"Statins and epilepsy: preclinical studies, clinical trials and statin-anticonvulsant drug interactions","volume":"16","author":"Scicchitano","year":"2015","journal-title":"Curr Drug Targets"},{"issue":"9","key":"10.1016\/j.gendis.2025.101945_bib164","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1007\/s00018-009-9018-5","article-title":"Digoxin and ouabain increase the synthesis of cholesterol in human liver cells","volume":"66","author":"Campia","year":"2009","journal-title":"Cell Mol Life Sci"},{"issue":"8","key":"10.1016\/j.gendis.2025.101945_bib165","doi-asserted-by":"crossref","first-page":"573","DOI":"10.5306\/wjco.v11.i8.573","article-title":"Statins in risk-reduction and treatment of cancer","volume":"11","author":"Barbalata","year":"2020","journal-title":"World J Clin Oncol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib166","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/s12951-021-01058-1","article-title":"Simvastatin induced ferroptosis for triple-negative breast cancer therapy","volume":"19","author":"Yao","year":"2021","journal-title":"J Nanobiotechnol"},{"issue":"11","key":"10.1016\/j.gendis.2025.101945_bib167","doi-asserted-by":"crossref","first-page":"8727","DOI":"10.1007\/s11033-020-05918-1","article-title":"Rosuvastatin inhibit spheroid formation and epithelial-mesenchymal transition (EMT) in prostate cancer PC-3 cell line","volume":"47","author":"Deezagi","year":"2020","journal-title":"Mol Biol Rep"},{"issue":"9","key":"10.1016\/j.gendis.2025.101945_bib168","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/s41416-021-01529-0","article-title":"Atorvastatin facilitates chemotherapy effects in metastatic triple-negative breast cancer","volume":"125","author":"Marti","year":"2021","journal-title":"Br J Cancer"},{"issue":"7","key":"10.1016\/j.gendis.2025.101945_bib169","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.2174\/1871520621666210602133005","article-title":"Atorvastatin enhances inhibitory effects of irradiation on tumor growth by reducing MSH2 expression both in prostate cancer cells and xenograft tumor models","volume":"22","author":"He","year":"2022","journal-title":"Anti Cancer Agents Med Chem"},{"issue":"6","key":"10.1016\/j.gendis.2025.101945_bib170","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3390\/antiox13060679","article-title":"Lovastatin-induced mitochondrial oxidative stress leads to the release of mtDNA to promote apoptosis by activating cGAS-STING pathway in human colorectal cancer cells","volume":"13","author":"Huang","year":"2024","journal-title":"Antioxidants"},{"issue":"8","key":"10.1016\/j.gendis.2025.101945_bib171","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1016\/j.bbagen.2013.04.011","article-title":"Simvastatin induced HCT116 colorectal cancer cell apoptosis through p38MAPK-p53-survivin signaling cascade","volume":"1830","author":"Chang","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib172","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s12964-023-01359-y","article-title":"Simvastatin induces pyroptosis via ROS\/caspase-1\/GSDMD pathway in colon cancer","volume":"21","author":"Xie","year":"2023","journal-title":"Cell Commun Signal"},{"issue":"4","key":"10.1016\/j.gendis.2025.101945_bib173","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/ijc.23593","article-title":"Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice","volume":"123","author":"Cho","year":"2008","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.gendis.2025.101945_bib174","first-page":"915","article-title":"Erratum: Atorvastatin exhibits anti-tumorigenic and anti-metastatic effects in ovarian cancer in vitro","volume":"8","author":"Jones","year":"2018","journal-title":"Am J Cancer Res"},{"issue":"5","key":"10.1016\/j.gendis.2025.101945_bib175","doi-asserted-by":"crossref","first-page":"345","DOI":"10.5414\/CP202275","article-title":"Evaluation of a potential transporter-mediated drug interaction between rosuvastatin and pradigastat, a novel DGAT-1 inhibitor","volume":"53","author":"Kulmatycki","year":"2015","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.gendis.2025.101945_bib176","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112335","article-title":"Rosuvastatin based novel 3-substituted isocoumarins\/3-alkylidenephthalides: ultrasound assisted synthesis and identification of new anticancer agents","volume":"201","author":"Kumar","year":"2020","journal-title":"Eur J Med Chem"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib177","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1080\/10717544.2022.2120925","article-title":"Pitavastatin-loaded bilosomes for oral treatment of hepatocellular carcinoma: a repurposing approach","volume":"29","author":"Kharouba","year":"2022","journal-title":"Drug Deliv"},{"issue":"4","key":"10.1016\/j.gendis.2025.101945_bib178","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1248\/bpb.29.634","article-title":"Anti-inflammatory effect of pitavastatin on NF-kappaB activated by TNF-alpha in hepatocellular carcinoma cells","volume":"29","author":"Wang","year":"2006","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib179","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/hep.28506","article-title":"Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: results from ERCHIVES","volume":"64","author":"Simon","year":"2016","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.gendis.2025.101945_bib180","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1002\/hep4.1991","article-title":"Atorvastatin favorably modulates a clinical hepatocellular carcinoma risk gene signature","volume":"6","author":"Kim","year":"2022","journal-title":"Hepatol Commun"},{"issue":"8","key":"10.1016\/j.gendis.2025.101945_bib181","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3727\/096504013X13657689382897","article-title":"Simvastatin inhibits proliferation and induces apoptosis in human lung cancer cells","volume":"20","author":"Yu","year":"2013","journal-title":"Oncol Res"},{"issue":"4","key":"10.1016\/j.gendis.2025.101945_bib182","doi-asserted-by":"crossref","first-page":"406","DOI":"10.7150\/ijbs.23542","article-title":"Simvastatin suppresses proliferation and migration in non-small cell lung cancer via pyroptosis","volume":"14","author":"Wang","year":"2018","journal-title":"Int J Biol Sci"},{"issue":"8","key":"10.1016\/j.gendis.2025.101945_bib183","first-page":"4263","article-title":"Simvastatin is beneficial to lung cancer progression by inducing METTL3-induced m6A modification on EZH2 mRNA","volume":"24","author":"Chen","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"5","key":"10.1016\/j.gendis.2025.101945_bib184","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/ijcp.12598","article-title":"Correlation between use of simvastatin and lovastatin and female lung cancer risk: a nationwide case-control study","volume":"69","author":"Yang","year":"2015","journal-title":"Int J Clin Pract"},{"issue":"9","key":"10.1016\/j.gendis.2025.101945_bib185","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1177\/2047487317691874","article-title":"Efficacy and safety of statins and exercise combination therapy compared to statin monotherapy in patients with dyslipidaemia: a systematic review and meta-analysis","volume":"24","author":"Gui","year":"2017","journal-title":"Eur J Prev Cardiol"},{"issue":"10","key":"10.1016\/j.gendis.2025.101945_bib186","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s11883-023-01142-x","article-title":"Fixed combination for the treatment of dyslipidaemia","volume":"25","author":"Ferri","year":"2023","journal-title":"Curr Atheroscler Rep"},{"issue":"2","key":"10.1016\/j.gendis.2025.101945_bib187","article-title":"Targeting the mevalonate pathway potentiates NUAK1 inhibition-induced immunogenic cell death and antitumor immunity","volume":"6","author":"Gui","year":"2025","journal-title":"Cell Rep Med"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib188","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40164-022-00292-z","article-title":"Targeting metabolic reprogramming in chronic lymphocytic leukemia","volume":"11","author":"Nie","year":"2022","journal-title":"Exp Hematol Oncol"},{"issue":"9","key":"10.1016\/j.gendis.2025.101945_bib189","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1136\/annrheumdis-2019-216599","article-title":"Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis","volume":"79","author":"Pinal-Fernandez","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.gendis.2025.101945_bib190","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1001\/jamaneurol.2018.2598","article-title":"Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies","volume":"75","author":"Mariampillai","year":"2018","journal-title":"JAMA Neurol"},{"issue":"6","key":"10.1016\/j.gendis.2025.101945_bib191","doi-asserted-by":"crossref","first-page":"e507","DOI":"10.1212\/WNL.0000000000004923","article-title":"Necrosis in anti-SRP+ and anti-HMGCR+ myopathies: role of autoantibodies and complement","volume":"90","author":"Allenbach","year":"2018","journal-title":"Neurology"},{"issue":"34","key":"10.1016\/j.gendis.2025.101945_bib192","doi-asserted-by":"crossref","first-page":"15051","DOI":"10.1073\/pnas.0910258107","article-title":"Dysregulation of the mevalonate pathway promotes transformation","volume":"107","author":"Clendening","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.gendis.2025.101945_bib193","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197422","article-title":"Lipophilic statins limit cancer cell growth and survival, via involvement of Akt signaling","volume":"13","author":"Beckwitt","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.gendis.2025.101945_bib194","doi-asserted-by":"crossref","DOI":"10.1155\/cdr\/6684099","article-title":"A meta-analysis of the incidence of adverse reactions of statins in various diseases","volume":"2025","author":"Li","year":"2025","journal-title":"Cardiovasc Ther"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib195","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/s12935-024-03573-1","article-title":"Integrated proteomics and metabolomics analyses reveal new insights into the antitumor effects of valproic acid plus simvastatin combination in a prostate cancer xenograft model associated with downmodulation of YAP\/TAZ signaling","volume":"24","author":"Iannelli","year":"2024","journal-title":"Cancer Cell Int"},{"issue":"7","key":"10.1016\/j.gendis.2025.101945_bib196","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/COC.0000000000001012","article-title":"Association between statin exposure and incidence and prognosis of prostate cancer: a meta-analysis based on observational studies","volume":"46","author":"Cao","year":"2023","journal-title":"Am J Clin Oncol"},{"issue":"8","key":"10.1016\/j.gendis.2025.101945_bib197","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/cac2.70036","article-title":"Simvastatin overcomes the pPCK1-pLDHA-SPRINGlac axis-mediated ferroptosis and chemo-immunotherapy resistance in AKT-hyperactivated intrahepatic cholangiocarcinoma","volume":"45","author":"Zhu","year":"2025","journal-title":"Cancer Commun (Lond)"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib198","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/ijc.28950","article-title":"Enhancement of tumor uptake and therapeutic efficacy of EGFR-targeted antibody cetuximab and antibody-drug conjugates by cholesterol sequestration","volume":"136","author":"Chen","year":"2015","journal-title":"Int J Cancer"},{"issue":"20","key":"10.1016\/j.gendis.2025.101945_bib199","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1111\/bph.17309","article-title":"Off-target effects of statins: molecular mechanisms, side effects and the emerging role of kinases","volume":"181","author":"Lagunas-Rangel","year":"2024","journal-title":"Br J Pharmacol"},{"issue":"6","key":"10.1016\/j.gendis.2025.101945_bib200","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/jcpt.13025","article-title":"Pharmacogenetics of statins treatment: efficacy and safety","volume":"44","author":"Guan","year":"2019","journal-title":"J Clin Pharm Therapeut"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib201","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00395-024-01046-0","article-title":"Early microvascular coronary endothelial dysfunction precedes pembrolizumab-induced cardiotoxicity. Preventive role of high dose of atorvastatin","volume":"120","author":"Efentakis","year":"2025","journal-title":"Basic Res Cardiol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101945_bib202","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005940","article-title":"Statin drugs enhance responses to immune checkpoint blockade in head and neck cancer models","volume":"11","author":"Kansal","year":"2023","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.gendis.2025.101945_bib203","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.semcdb.2017.10.019","article-title":"Underlying mechanisms for sterol-induced ubiquitination and ER-associated degradation of HMG CoA reductase","volume":"81","author":"Johnson","year":"2018","journal-title":"Semin Cell Dev Biol"}],"container-title":["Genes & Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304225004349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304225004349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T15:29:27Z","timestamp":1777303767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352304225004349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":203,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2352304225004349"],"URL":"https:\/\/doi.org\/10.1016\/j.gendis.2025.101945","relation":{},"ISSN":["2352-3042"],"issn-type":[{"value":"2352-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging roles of the metabolic regulator 3-hydroxy-3-methylglutaryl coenzyme-CoA reductase in human cancers: From biology to therapeutics","name":"articletitle","label":"Article Title"},{"value":"Genes & Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gendis.2025.101945","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101945"}}